- Home
- WGS
as 12-17-2024 4:00pm EST
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | STAMFORD |
| Market Cap: | 2.0B | IPO Year: | N/A |
| Target Price: | $67.00 | AVG Volume (30 days): | 498.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.76 - $89.11 | Next Earning Date: | 10-29-2024 |
| Revenue: | $267,228,000 | Revenue Growth: | 29.41% |
| Revenue Growth (this year): | 43.7% | Revenue Growth (next year): | 16.78% |
Latest GeneDx Holdings Corp. News
WGS Breaking Stock News: Dive into WGS Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Simply Wall St.
8 days ago
GeneDx Holdings Corp. (NASDAQ:WGS): Is Breakeven Near?
Business Wire
13 days ago
GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners
Barrons.com
19 days ago
Sleep Number, Getty Images, and More Stocks See Action From Activist Investors
MT Newswires
22 days ago
GeneDx Holdings Insider Sold Shares Worth $1,645,810, According to a Recent SEC Filing
Investor's Business Daily
23 days ago
This Once Ultracheap Biotech Stock Rockets 2,762%, Nears Buy Point After Big Earnings Win
Business Wire
a month ago
GeneDx to Participate in Upcoming Investor Conference
MT Newswires
a month ago
GeneDx Holdings Insider Sold Shares Worth $3,316,880, According to a Recent SEC Filing
Compare WGS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "WGS GeneDx Holdings Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.